Literature DB >> 7992810

Absorption of subcutaneous injection of Tc-99m pertechnetate via acupuncture points and non-acupuncture points.

C C Wu1, M F Chen, C C Lin.   

Abstract

SC-RNV, a new method of radionuclide venography by subcutaneous injection of Tc-99m pertechnetate at acupuncture points K-3 (Taixi), was developed in our laboratory. To further investigate whether K-3 is the best point for SC-RNV, Tc-99m pertechnetate was subcutaneously injected at K-3 on one foot and at one of the 11 other acupuncture points (APs) or 3 nonacupuncture points (NAPs) on the opposite foot, simultaneously, in 157 subjects without evidence of venous disorder. The absorption of radioisotopes from each injection site was evaluated by analyzing the time-activity curve at a region of interest set upon over the lower leg above the injection site. The results revealed that the absorption of radioisotopes via K-3 (Taixi) was better than that via NAPs, evidenced by higher peak activity and greater absorption rate. However, there was no significant difference between K-3 injection and other APs injections except Liv-2 and Liv-3. These results indicate that absorption of radioisotopes via APs is better than via NAPs. This together with the fact that K-3 is easier to detect than other APs in feet, suggests that K-3 is a good point for SC-RNV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7992810     DOI: 10.1142/S0192415X94000140

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  2 in total

1.  In Vivo Visualization of the Pericardium Meridian with Fluorescent Dyes.

Authors:  Tongju Li; Bruce Qing Tang; Wei-Bo Zhang; Minyi Zhao; Qingchuan Hu; Andrew Ahn
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-29       Impact factor: 2.629

2.  Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis.

Authors:  Shujing Ren; Heng Liu; Xitong Wang; Jiquan Bi; Shengfeng Lu; Chenqi Zhu; Huizhu Li; Wenliang Kong; Rui Chen; Zhipeng Chen
Journal:  J Nanobiotechnology       Date:  2021-12-07       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.